At ARDD 2025 in Copenhagen, Andrew Adams (Eli Lilly) and Lotte Bjerre Knudsen (Novo Nordisk) joined our global community to discuss the longevity potential of GLP-1, marking the first time leaders from two of the worlds largest pharmaceutical companies publicly talked about whether these drugs could slow or prevent multiple age-related diseases
Their destructive action on endothelial cells is enhanced when they act as aggregates rather than monomers
However, a considerable proportion of affected individuals experience a protracted recovery [11, 12], highlighting the potential for significant and prolonged morbidity
RELATED STORY | So, you've lost weight using Wegovy
That makes it easier to overshoot carb targets and harder for semaglutide to stabilize appetite
So while it is produced naturally by the body, it can also be supplemented through oral, topical, or intravenous means to enhance its effects